Bahrain vs Denmark: The number of people with susceptibility test result for rifampicin
Bahrain
112
in 2021
Denmark
113
in 2021
Bahrain rank
107th
Denmark rank
106th
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Denmark
How they compare
Denmark currently reports 113 against 112 in Bahrain, a difference of 1.
Across all 5 years both countries report, Denmark has been ahead every year.
Bahrain ranks 107th and Denmark ranks 106th of 155 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Denmark | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84 | 162 | 78 | Denmark |
| 2020s | 97 | 120.5 | 23.5 | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Denmark?
- Denmark, at 113 against 112 in Bahrain as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Denmark?
- 1, with Denmark ahead.
- How many years of comparable data are there for Bahrain and Denmark?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Denmark rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 107th and Denmark ranks 106th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.